|
|
Article: Announcing American International Biotechnology Services.
- Article from:
- Clinical Trials Week
- Article date:
- November 16, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Bostwick Laboratories[R] announces the acquisition of the assets and infrastructure of CBI Services and Fairfax Identity Laboratories, formerly business units within Commonwealth Biotechnologies Inc. CBI Services is now American International Biotechnology Services (AIBioTech) and will operate as a division of American International Pathology Laboratories (AIPL), while Fairfax Identity Laboratories (FIL) will retain its existing identity (see also Bostwick Laboratories).
AIBioTech and FIL will retain their full complement of life sciences and DNA identity support services that have made them the providers of choice to investigators in government, university, and ...